Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
KURA Kura Oncology, Inc. daily Stock Chart
KURA [NASD]
Kura Oncology, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.53 Insider Own15.61% Shs Outstand46.55M Perf Week-1.43%
Market Cap575.82M Forward P/E- EPS next Y-1.92 Insider Trans- Shs Float38.24M Perf Month-2.52%
Income-61.40M PEG- EPS next Q-0.41 Inst Own87.00% Short Float6.61% Perf Quarter-14.36%
Sales- P/S- EPS this Y-12.60% Inst Trans-1.36% Short Ratio8.81 Perf Half Y-30.11%
Book/sh5.16 P/B2.40 EPS next Y-25.50% ROA-28.10% Target Price27.86 Perf Year-17.81%
Cash/sh5.37 P/C2.30 EPS next 5Y19.93% ROE-31.00% 52W Range11.41 - 21.42 Perf YTD-10.04%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-42.58% Beta2.49
Dividend %- Quick Ratio19.30 Sales past 5Y- Gross Margin- 52W Low7.78% ATR0.45
Employees51 Current Ratio19.30 Sales Q/Q- Oper. Margin- RSI (14)46.61 Volatility4.31% 3.70%
OptionableYes Debt/Eq0.00 EPS Q/Q8.80% Profit Margin- Rel Volume0.40 Prev Close12.37
ShortableYes LT Debt/Eq0.03 EarningsMar 03 AMC Payout- Avg Volume286.80K Price12.30
Recom1.60 SMA201.90% SMA50-6.91% SMA200-22.43% Volume70,217 Change-0.57%
Jul-18-19Initiated Deutsche Bank Buy $28
Nov-09-18Initiated Piper Jaffray Overweight
Aug-01-18Initiated H.C. Wainwright Buy $31
Oct-13-16Resumed Leerink Partners Outperform $15
Jan-22-16Initiated JMP Securities Mkt Outperform
Dec-30-15Initiated Oppenheimer Outperform $16
Dec-16-15Initiated Citigroup Buy
Feb-19-20 04:05PM  Kura Oncology to Participate in Three Upcoming Investor Conferences GlobeNewswire
Feb-18-20 04:05PM  Kura Oncology to Report Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Jan-24-20 10:44AM  The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study Benzinga
Jan-23-20 04:05PM  Kura Oncology Announces Transition of Chief Medical Officer GlobeNewswire
Jan-21-20 04:09AM  3 Healthcare Stocks That Can Double in the Next Year TipRanks
Jan-09-20 07:30AM  Kura Oncology to Present at J.P. Morgan Healthcare Conference GlobeNewswire
Jan-06-20 07:30AM  Kura Oncology Appoints Kirsten Flowers as Chief Commercial Officer GlobeNewswire
Dec-16-19 07:30AM  Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial GlobeNewswire
Dec-10-19 02:21PM  Kura Oncology, Inc. (KURA): Hedge Funds Cant Make Up Their Minds Insider Monkey
Dec-08-19 12:00PM  Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma GlobeNewswire
Nov-26-19 07:30AM  Kura Oncology to Participate in Piper Jaffray Healthcare Conference GlobeNewswire
Nov-25-19 05:51AM  Kura Oncology Requires Plenty of Patience by Investors TheStreet.com
Nov-15-19 04:29PM  Edited Transcript of KURA earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 07:30AM  Kura Oncology to Present at Stifel Healthcare Conference GlobeNewswire
Nov-09-19 02:26PM  Hedge Funds Have Never Been This Bullish On Kura Oncology, Inc. (KURA) Insider Monkey
Nov-06-19 09:06AM  Kura Oncology Announces Upcoming Presentation at ASH Annual Meeting GlobeNewswire
Nov-05-19 04:05PM  Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Nov-04-19 07:30AM  Kura Oncology Appoints James Basta as Chief Legal Officer GlobeNewswire
Oct-30-19 07:30AM  Kura Oncology to Report Third Quarter 2019 Financial Results GlobeNewswire
Oct-29-19 11:50AM  Kura Oncology Reports Durable Anti-Tumor Activity in Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer GlobeNewswire
Oct-23-19 04:05PM  Kura Oncology Data Selected for Oral Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire
Oct-16-19 04:30PM  Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire
Oct-15-19 07:30AM  Kura Oncology Expands Board of Directors with Appointment of Diane Parks GlobeNewswire
Oct-01-19 01:05AM  Edited Transcript of KURA earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-16-19 07:30AM  Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia GlobeNewswire
Sep-03-19 07:30AM  Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in HRAS Mutant Urothelial Carcinoma GlobeNewswire
Aug-29-19 07:30AM  Kura Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire
Aug-12-19 04:05PM  Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer GlobeNewswire -5.51%
Aug-07-19 07:30AM  Kura Oncology to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-03-19 12:08AM  Kura Oncology, Inc. (KURA) 2019 Q2 Earnings Call Transcript Motley Fool
Jul-25-19 07:30AM  Kura Oncology to Report Second Quarter 2019 Financial Results GlobeNewswire
Jul-24-19 07:30AM  Kura Oncologys Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia GlobeNewswire
Jul-11-19 07:30AM  Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents GlobeNewswire
Jul-02-19 09:15AM  Kura Oncology, Inc. (KURA) Shares March Higher, Can It Continue? Zacks
Jun-23-19 08:50AM  Do Insiders Own Shares In Kura Oncology, Inc. (NASDAQ:KURA)? Simply Wall St.
08:48AM  What Kind Of Investor Owns Most Of Kura Oncology, Inc. (NASDAQ:KURA)? Simply Wall St.
Jun-21-19 04:30PM  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jun-18-19 11:31PM  Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock GlobeNewswire
04:01PM  Kura Oncology Announces Commencement of Public Offering of Common Stock GlobeNewswire
10:46AM  Is Kura Oncology, Inc. (KURA) A Good Stock To Buy? Insider Monkey
Jun-17-19 09:31AM  Company News For Jun 17, 2019 Zacks
Jun-14-19 10:03AM  Kura Oncology Soars After Lymphoma Treatment Test Results TheStreet.com
07:48AM  Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal MarketWatch
07:00AM  Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma GlobeNewswire
May-15-19 12:14PM  Edited Transcript of KURA earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 01:15PM  Heres What Hedge Funds Think About Kura Oncology, Inc. (KURA) Insider Monkey
May-07-19 08:49PM  Kura Oncology, Inc. (KURA) Q1 2019 Earnings Call Transcript Motley Fool
05:54PM  Kura Oncology: 1Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones GlobeNewswire
Apr-30-19 07:30AM  Kura Oncology to Report First Quarter 2019 Financial Results GlobeNewswire
Apr-25-19 12:36PM  Edited Transcript of KURA earnings conference call or presentation 5-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Apr-02-19 04:04PM  Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression, Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications GlobeNewswire
Mar-29-19 07:10AM  Detailed Research: Economic Perspectives on Five Below, INVESCO MORTGAGE CAPITAL INC, Amicus Therapeutics, Akamai Technologies, Kura Oncology, and Columbus McKinnon What Drives Growth in Today's Competitive Landscape GlobeNewswire
Mar-27-19 07:16AM  The Kura Oncology (NASDAQ:KURA) Share Price Has Soared 317%, Delighting Many Shareholders Simply Wall St.
Mar-06-19 07:30AM  Kura Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire -7.29%
Mar-05-19 07:13PM  Kura Oncology, Inc. (KURA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:03PM  Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
07:30AM  Kura Oncology Announces FDA Clearance of Investigational New Drug Application for Menin-MLL Inhibitor KO-539 GlobeNewswire
Feb-26-19 07:30AM  Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-20-19 07:30AM  Kura Oncology to Present at SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-19-19 07:40AM  Detailed Research: Economic Perspectives on Tesla, Kura Oncology, ASML Holding N.V, Applied Industrial Technologies, Raven Industries, and Intra-Cellular Therapies What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jan-18-19 10:00AM  Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression GlobeNewswire
Jan-03-19 07:30AM  Kura Oncology to Present at J.P. Morgan Healthcare Conference GlobeNewswire
Dec-15-18 11:21PM  Kura Oncology, Inc. (KURA): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-03-18 09:19AM  Edited Transcript of KURA earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +10.63%
Dec-02-18 12:00PM  Kura Oncology Announces Proof of Concept in Angioimmunoblastic T-Cell Lymphoma, Validation of CXCL12 as a Therapeutic Target of Tipifarnib in Peripheral T-Cell Lymphoma GlobeNewswire
Nov-30-18 07:50AM  Report: Exploring Fundamental Drivers Behind J.B. Hunt Transport Services, Kura Oncology, National Beverage, Benefitfocus, PTC Therapeutics, and Walgreens Boots Alliance New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-28-18 07:30AM  Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma GlobeNewswire +6.48%
Nov-08-18 07:30AM  Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors GlobeNewswire
Nov-06-18 07:30AM  Kura Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire
Nov-05-18 06:14PM  Kura Oncology: 3Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
07:30AM  Kura Oncology Initiates Registration-Directed Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinomas GlobeNewswire
Nov-01-18 09:00AM  Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting GlobeNewswire
Oct-29-18 07:30AM  Kura Oncology to Report Third Quarter 2018 Financial Results GlobeNewswire
Oct-25-18 08:53AM  3 Beaten-Down Biotech Stocks: Can They Bounce Back? Motley Fool +5.75%
Oct-23-18 09:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Dropbox, Kura Oncology, DHT, Wayfair, US Foods Holding, and InflaRx N.V New Research Emphasizes Economic Growth GlobeNewswire
Oct-22-18 02:20PM  Here's Why Kura Oncology Fell Today Motley Fool -18.85%
08:45AM  Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC GlobeNewswire
Sep-26-18 04:05PM  Kura Oncology to Present at Leerink Partners Rare Disease & Oncology Roundtable GlobeNewswire
Aug-30-18 07:30AM  Kura Oncology to Present at H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-20-18 11:45AM  Edited Transcript of KURA earnings conference call or presentation 6-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 04:05PM  Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire -12.29%
Aug-06-18 04:36PM  Kura Oncology: 2Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Kura Oncology, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 07:30AM  Kura Oncology Appoints Marc Grasso, M.D., as Chief Financial Officer and Chief Business Officer GlobeNewswire
Jul-30-18 04:05PM  Kura Oncology to Report Second Quarter 2018 Financial Results GlobeNewswire
Jul-02-18 04:30PM  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jun-28-18 07:30AM  Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock GlobeNewswire
Jun-27-18 04:01PM  Kura Oncology Announces Commencement of Public Offering of Common Stock GlobeNewswire
Jun-20-18 07:30AM  Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial GlobeNewswire
Jun-14-18 07:30AM  Kura Oncology to Present at JMP Securities Life Sciences Conference GlobeNewswire
May-22-18 07:00AM  OncoDNA announces screening collaboration with Kura Oncology GlobeNewswire
May-14-18 07:51PM  Edited Transcript of KURA earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-08-18 07:14PM  Kura Oncology: 1Q Earnings Snapshot Associated Press
04:05PM  Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-03-18 07:30AM  Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference GlobeNewswire
May-02-18 07:30AM  Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies GlobeNewswire
May-01-18 07:30AM  Kura Oncology to Report First Quarter 2018 Financial Results GlobeNewswire
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidate is Tipifarnib, an oral farnesyl transferase inhibitor that is in Phase II clinical trials for the treatment of solid tumors, peripheral T-cell lymphomas, myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. It is also developing KO-947, a small molecule inhibitor of extracellular signal related kinase used for the treatment of patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway; and KO-539, a small molecule inhibitor of the menin-mixed lineage leukemia protein-protein interaction. The company was founded in 2014 and is headquartered in San Diego, California.
open in yahoo | open in reuters | open in google